These followed two deals late last week – on Thursday GSK made an $85 million licensing agreement with Surface Oncology for an early-stage antibody asset, which adds a natural killer cell ...

Walmsley said there is a lot of data expected in 2020. Walmsley said in the interview that the next year could see “at least six approvals of new medicines or new indications”. GSK is asking ...

NEW YORK (Reuters) - Drugmakers including Pfizer Inc <PFE.N>, GlaxoSmithKline PLC <GSK.L ... is running for re-election in 2020. Many branded drugmakers have pledged to keep their US list price ...

Sales of GSK (NYSE:GSK) and Pfizer’s (NYSE:PFE) RSV vaccines have reportedly fallen since U.S. regulators narrowed the ...

You can also contact the Law Offices of Frank R. Cruz to discuss your legal rights by email at [email protected], by telephone at (310) 914-5007, or visit our website at www.frankcruzlaw.com .

Law Offices of Howard G. Smith reminds investors of the upcoming April 7, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased GSK plc. ("GSK" or the ...